Wealth Enhancement Advisory Services, LLC Crispr Therapeutics Ag Transaction History
Wealth Enhancement Advisory Services, LLC
- $46.2 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 36,139 shares of CRSP stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,139
Previous 30,241
19.5%
Holding current value
$1.43 Million
Previous $1.42 Million
0.07%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
57.9MCall Options Held
1.1MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$315 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$298 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$119 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$118 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$118 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.1B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....